Landos Biopharma (LABP) Stock Chart & Stock Price History → Are You Positioned For The New Energy Goldrush? (From Wealthpin Pro) (Ad) Free LABP Stock Alerts $22.93 +0.13 (+0.57%) (As of 05/23/2024) Add Compare Share Share ChartStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends Landos Biopharma Stock Price Performance5 Day Performance0.00%1 Month Performance+3.06%3 Month Performance+261.10%6 Month Performance+449.88%Year-To-Date Performance+526.50%1 Year Performance+686.62% Receive LABP Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Landos Biopharma and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Porter & CompanyThis military-backed stock “owns” AI marketThe AI boom is just getting started. And the real wealth has still to be made…You must read this new presentation from Porter Stansberry. LABP Stock Chart for Sunday, June, 2, 2024 LABP Chart by TradingView Landos Biopharma Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/31/2024$22.93$22.93$22.94$22.7550,800 shs$71.77 million05/30/2024$22.93$22.93$22.94$22.7550,800 shs$71.77 million05/29/2024$22.93$22.93$22.94$22.7550,800 shs$71.77 million05/28/2024$22.93$22.93$22.94$22.7550,800 shs$71.77 million05/27/2024$22.93$22.93$22.94$22.7550,800 shs$71.77 million05/24/2024$22.93$22.93$22.94$22.7550,899 shs$71.77 million Get the Latest News and Ratings for LABP and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Landos Biopharma and its competitors with MarketBeat's FREE daily newsletter. 05/23/2024$22.80$22.93+0.57%$22.94$22.7550,268 shs$71.77 million05/22/2024$22.30$22.80+2.24%$22.88$22.3635,001 shs$71.36 million05/21/2024$22.21$22.30+0.41%$22.40$22.2510,096 shs$69.80 million05/20/2024$22.47$22.21-1.16%$22.46$22.2017,977 shs$69.52 million05/17/2024$22.30$22.47+0.76%$22.47$22.3312,927 shs$70.24 million05/16/2024$22.35$22.30-0.22%$22.46$22.295,739 shs$69.80 million05/15/2024$22.45$22.35-0.45%$22.45$22.3012,273 shs$69.96 million05/14/2024$22.29$22.45+0.72%$22.58$22.252,386 shs$70.27 million05/13/2024$22.33$22.29-0.18%$22.42$22.133,896 shs$69.77 million05/10/2024$22.36$22.33-0.13%$22.38$22.1310,749 shs$69.67 million05/09/2024$22.20$22.36+0.72%$22.48$22.135,051 shs$69.76 million05/08/2024$22.17$22.20+0.14%$22.21$22.125,249 shs$69.26 million05/07/2024$22.15$22.17+0.09%$22.29$22.127,834 shs$69.17 million05/06/2024$22.24$22.15-0.38%$22.20$22.026,357 shs$69.11 million05/03/2024$22.25$22.24-0.07%$22.43$22.193,862 shs$69.37 million05/02/2024$22.30$22.25-0.22%$22.36$21.916,316 shs$69.42 million05/01/2024$22.30$22.30$22.46$22.159,671 shs$69.58 million04/30/2024$22.38$22.30-0.36%$22.46$22.181,676 shs$69.58 million04/29/2024$22.31$22.38+0.31%$22.49$22.203,963 shs$69.83 million04/26/2024$22.35$22.21-0.63%$22.55$22.2114,876 shs$69.30 million04/25/2024$22.36$22.35-0.04%$22.84$22.213,928 shs$69.73 million04/24/2024$22.15$22.36+0.95%$22.49$22.079,082 shs$69.76 million04/23/2024$21.96$22.15+0.87%$22.15$21.909,225 shs$69.11 million04/22/2024$21.82$21.96+0.64%$22.10$21.6113,185 shs$68.52 million04/19/2024$21.76$21.82+0.28%$21.82$21.6014,682 shs$68.08 million04/18/2024$21.67$21.76+0.42%$21.76$21.5520,783 shs$67.83 million04/17/2024$21.51$21.67+0.74%$21.72$21.4615,314 shs$67.61 million04/16/2024$21.57$21.51-0.28%$21.56$21.4319,143 shs$67.11 million04/15/2024$21.54$21.57+0.15%$21.57$21.4318,703 shs$67.30 million04/12/2024$21.51$21.54+0.14%$21.58$21.503,050 shs$67.21 million04/11/2024$21.56$21.51-0.21%$21.63$21.5135,409 shs$67.11 million04/10/2024$21.53$21.56+0.12%$21.60$21.4631,043 shs$67.25 million04/09/2024$21.50$21.53+0.14%$21.59$21.4918,908 shs$67.17 million04/08/2024$21.61$21.50-0.51%$21.79$21.4734,509 shs$67.02 millionWhat is Nvidia doing on June 10? June 10th is pivotal for Nvidia’s “Silent Partners” (Ad)A small handful of companies are working with Nvidia to help ensure that this pivot is a massive success. We call them Nvidia’s “Silent Partners.”Click here to find out who they are.04/05/2024$21.55$21.61+0.28%$21.64$21.4627,999 shs$67.42 million04/04/2024$21.49$21.55+0.28%$21.74$21.4518,593 shs$67.17 million04/03/2024$21.52$21.49-0.14%$21.67$21.4525,034 shs$67.05 million04/02/2024$21.60$21.52-0.37%$21.60$21.4538,699 shs$67.14 million04/01/2024$21.48$21.60+0.56%$21.76$21.4330,615 shs$67.39 million03/29/2024$21.50$21.48-0.09%$21.87$21.3547,103 shs$66.95 million03/28/2024$21.36$21.50+0.66%$21.82$21.3547,101 shs$67.08 million03/27/2024$21.56$21.36-0.93%$21.64$21.3544,644 shs$66.64 million03/26/2024$21.41$21.56+0.70%$21.80$21.3666,055 shs$67.27 million03/25/2024$7.83$21.41+173.44%$21.87$21.11570,043 shs$66.80 million03/22/2024$7.67$7.83+2.09%$8.08$7.707,105 shs$24.43 million03/21/2024$6.99$7.67+9.73%$7.90$7.0010,985 shs$23.93 million03/20/2024$6.94$6.99+0.72%$7.29$6.903,924 shs$21.81 million03/19/2024$6.64$6.94+4.52%$7.35$6.6418,645 shs$21.63 million03/18/2024$6.64$6.64$6.68$6.3110,867 shs$20.72 million03/15/2024$6.48$6.64+2.47%$6.64$6.302,837 shs$20.72 million03/14/2024$6.48$6.48$6.60$6.266,083 shs$20.20 million03/13/2024$6.53$6.48-0.77%$6.68$6.254,915 shs$20.22 million03/12/2024$6.25$6.53+4.48%$6.53$6.065,071 shs$20.37 million03/11/2024$6.24$6.25+0.16%$6.68$5.5721,315 shs$19.50 million03/08/2024$6.51$6.24-4.15%$6.64$6.0123,637 shs$19.47 million03/07/2024$6.61$6.51-1.51%$6.58$6.0047,492 shs$20.31 million03/06/2024$6.51$6.61+1.54%$6.73$6.413,906 shs$20.62 million03/05/2024$6.57$6.51-0.91%$6.63$6.395,736 shs$20.29 million03/04/2024$6.35$6.57+3.46%$6.57$6.2713,858 shs$20.50 million03/01/2024$6.34$6.35+0.16%$6.55$6.246,660 shs$19.81 million Related Companies: Achilles Therapeutics Stock Price Chart Aspira Women's Health Stock Price Chart Sensei Biotherapeutics Stock Price Chart Gossamer Bio Stock Price Chart Adverum Biotechnologies Stock Price Chart Nature's Sunshine Products Stock Price Chart Xeris Biopharma Stock Price Chart Aquestive Therapeutics Stock Price Chart Revance Therapeutics Stock Price Chart ESSA Pharma Stock Price Chart Receive LABP Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Landos Biopharma and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:LABP) was last updated on 6/2/2024 by MarketBeat.com Staff From Our PartnersTrump’s Gift Could Unleash $51 Billion in New WealthWealthpin ProBiden replacement revealed?Paradigm PressBiden Nomination CANCELED?The Freeport SocietyBuy this small stock before coming AI Tidal WaveChaikin AnalyticsWarren Buffett, Jeff Bezos, Michael Bloomberg, & 48 Members of Congress Are Buying ONE Sector…InvestorPlaceNvidia has Apple and Microsoft within striking rangeWeiss RatingsDon’t buy a single NVIDIA share before you see this...Behind the MarketsExposed: 10 CENT Crypto to Explode May 20th?True Market Insiders Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Landos Biopharma, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.